JuanCalleMD

PubMed

• 2 citations
  Diagnosis and management of primary hyperoxalurias: best practices.
  Mini Michael, Elizabeth Harvey, Dawn S Milliner, Yaacov Frishberg, David J Sas
  Pediatric Nephrology. 2024-11-01
• 1 citations
  Cardiac Surgery Outcomes in Patients Receiving Hemodialysis Versus Peritoneal Dialysis.
  Elias Bassil, Milad Matta, Haytham El Gharably, Serge Harb, Juan Calle
  Kidney Medicine. 2024-03-01
• 1 citations
  End Point Considerations for Clinical Trials in Enteric Hyperoxaluria.
  Craig B Langman, Dean Assimos, Melanie Blank, Juan Calle, Andreas Grauer
  Clinical Journal of the American Society of Nephrology. 2023-12-01

Journal Articles

• Relationship between Patient’s Demographics and Stone Composition in Men and Women  
  Omar M, Monga M, Calle JC, J Nephrol Ther, 1/1/2015
• Urinary Podocyte Excretion and Proteinuria in Patients Treated with Antivascular Endothelial Growth Factor Therapy for Solid Tumor Malignancies  
  Hayman SR, Calle JC, Jatoi A, Craici IM, Wagner SJ, Weaver AL, Greene EL, Grande JP, Garovic VD, Oncology, 1/4/2014
• Can 24-Hour Urine Stone Risk Profiles Predict Urinary Stone Composition?  
  Torricelli FC, De S, Liu X, Calle J, Gebreselassie S, Monga M, J Endourol, 1/1/2014
• How to prevent stone formation in patients with metabolic syndrome  
  Calle JC, Monga M, Urology Times, 1/1/2014
• Impact of Stone Disease: Chronic Kidney Disease and Quality of Life  
  Kartha, G; Calle, JC; Marchini, GS; Monga, M, Urol Clin North Am, 1/1/2013
• Night Sweats Revisited  
  Franco-Paredes, Carlos; Mehrabi, Don; Calle, Juan C.; Jurado, Rafael L, Infectious Diseases in Clinical Practice, 1/1/2002
• Join now to see all

Books/Book Chapters

• Pocket Guide to Kidney Stone Prevention 
  Chapter: What Is the Risk of Stone Recurrence? 
  Page 3 - 7Juan C. CalleEditors: Manoj Monga, Kristina L. Penniston, David S. Goldfarb.Springer International Publishing, Switzerland2015
• Practical Controversies in Medical Management of Stone Disease 
  Chapter: Metabolic Evaluation: Underuse or Overdone? 
  Page 1 - 6Juan C. Calle and Manoj MongaEditors: Margaret S. Pearle; Stephen Y. Nakada.Springer Science + Business Media, New York, NY2014

Abstracts/Posters

• Mortality in Kidney Disease Patients Treated with Phosphate Binders: A Randomized Study
  Calle, Juan C, Mayo Clinic, Division of Nephrology and Hypertension; Clin J Am Soc Nephrol, Rochester, MN, 1/8/2012
• Ten Year Outcome after Rapid Discontinuation of Prednisone in Adult Primary Kidney Transplantation
  Calle, Juan C, Mayo Clinic, Division of Nephrology and Hypertension; Clin J Am Soc Nephrol, Rochester, MN, 1/2/2012
• Circulating Urokinase Receptor as a Cause of Focal Segmental Glomerulosclerosis
  Calle, Juan C, Mayo Clinic, Division of Nephrology and Hypertension; Nat. Med., 1/28/2011
• Early Childhood Membranous Nephropathy Due to Cationic Bovine Serum Albumin
  Calle, Juan C, Mayo Clinic, Division of Nephrology and Hypertension; N Engl J Med, Rochester, MN, 1/8/2011
• Prevention of Dialysis Catheter Malfunction with Recombinant Tissue Plasminogen Activator
  Calle, Juan C, Mayo Clinic, Division of Nephrology and Hypertension; N Engl J Med, Rochester, MN, 1/4/2011
• Podocyturia is an early marker that distinguishes among normotensive pregnancy, gestational hypertension, and preeclampsia
  Craici I, Wagner S, Calle JC, Wood-Wentz C, Bailey K, Turner S, Grande J, Garovic V, J Am Soc Nephrol, 1/1/2011
• Podocyturia in patients treated with anti-VEGF therapy for cancer correlates with the level of proteinuria
  Calle JC, Craici I, Wagner S, Jatoi A, Greene E, Grande JP, Garovic V, J Am Soc Nephrol, 1/1/2011
• Podocyturia in Patients Treated with anti-VEGF Therapy for Cancer
  Calle, J; Craici, Iasmina; Wagner, Steve; Jatoi, Aminah; Grande, Joseph; Garovic, Vesna, Am J Kidney Dis, 1/1/2011
• A new function for parietal cells: a second glomerular barrier
  Calle, Juan C, Mayo Clinic, Division of Nephrology and Hypertension; Am J Physiol, Rochester, MN, 1/29/2010
• Urine Podocyte mRNAs Mark Progression of Renal Disease
  Calle, Juan C, Mayo Clinic, Division of Nephrology and Hypertension; J Am Soc Nephrol, Rochester, MN, 1/28/2010
• Relationship Between BK Viremia, BK Nephropathy, and the Use of T Cell Depleting vs. Non Depleting Induction Agents (3131)
  Calle, J.; Palacios, Franco C.; Cornell, L.; Langman, L.; Pritt, B. S.; Stegall, M. D.; Prieto, M.; Cosio, F.;, Amer, H. Transplantation, 1/27/2010
• Urinary Retinol Binding Protein (RBP) and Alpha One Microglobulin One Year Post Kidney Transplant: Relationship to Two Year Histology and Graft Survival (2690)
  Palacios, Franco C.; Lieske, J.; Calle, J.; Cornell, L.; Cosio, F.;, Amer, H. Transplantation, 1/27/2010
• Plasma Renin Activity Predicts Blood Pressure Responses to Beta-Blocker and Thiazide Diuretic as Monotherapy and Add-On Therapy for Hypertension
  Calle, Juan C, Mayo Clinic, Division of Nephrology and Hypertension; Am J Hypertens, Rochester, MN, 1/15/2010
• The Relationship between BK Viremia, BK Nephropathy and the Use of T cell Depleting vs. Non Depleting Induction Agents
  Juan C Calle, MD, Hatem Amer, MD, Carlos R Franco, MD, Lynn D Cornell, MD, Loralie J Langman, PhD, Bobbi S Pritt, MD, Mikel Prieto , MD, Mark D Stegall , MD, Fernando..., XXIII International Congress of the Transplantation Society, Vancouver, Canada, 1/15/2010
• Urinary Retinol Binding Protein (RBP) and Alpha One Microglobulin (alpha1m) at One Year Post Kidney Transplant: Relationship to Two Year Histology and Graft Survival
  Carlos R Franco, MD, John C Lieske, MD , Juan C Calle, MD , Lynn D Cornell, MD, Fernando G Cosio, MD and Hatem Amer, MD, XXIII International Congress of the Transplantation Society, Vancouver, Canada, 1/15/2010
• M-Type Phospholipase A 2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy
  Calle, Juan C, Mayo Clinic, Division of Nephrology and Hypertension; N Engl J Med, Rochester, MN, 1/1/2009
• Intensive Lipid Lowering With Atorvastatin in Patients with Coronary Artery Disease, Diabetes, and Chronic Kidney Disease
  Calle, Juan C, Mount Sinai Medical Center. Department of Internal Medicine; Mayo Clinic Proceedings, 1/1/2008
• Join now to see all

Lectures

• From the bones to the kidneys: kidney stones, vitamin D and PTH axis relationship 
  1/20/2015
• Medical Management of Complex Stones: Brushite, Struvite and Cystine Stones 
  Cleveland, OH - 1/14/2015
• Community-Based Parenteral Anti-Infective Therapy (COPAT) for ESRD Patients 
  San Diego, CA - 1/3/2015
• Supplemental Calcium Increases the Growth Rate of Renal Calculi in Stone Formers 
  San Diego, CA - 1/3/2015
• Effect of Calcium and Vitamin D Supplementation on Known Stone Formers' 24-hour Urine Panels 
  San Diego, CA - 1/3/2015
• Medical Therapy for Stone Disease 
  Cleveland, OH - 1/24/2014
• Simultaneous infusion of Eculizumab and intravenous immunoglobulin does not decrease the efficacy of Eculizumab 
  Philadelphia, PA - 1/11/2014
• AKI and percutaneous nephrolithotomy: the National Inpatient Database 
  Fort Lauderdale, FL - 1/7/2014
• Successful Medical Management of Recurrent Idiopathic Retroperitoneal Fibrosis 
  Las Vegas, NV - 1/22/2013
• Central Diabetic Insipidus Due to Herpes Simplex Encephalitis in a Multiple Sclerosis Immunosuppressed Patient 
  Las Vegas, NV - 1/22/2013
• Cleveland Rocks 
  1/16/2013
• Urolithiasis 
  Ritz Carlton, Cleveland, OH - 1/12/2013
• Nephrolithiasis: from nephrology to urology 
  Cleveland, OH - 1/10/2013
• Medical Therapy and Stone Disease 
  Cleveland, OH - 1/6/2013
• Effect of Hospital Volume on Acute Kidney Injury in Percutaneous Nephrolithotomy Admissions 
  Atlanta, GA - 1/4/2013
• Nephrolithiasis: There is more to it than simple rocks 
  Cleveland, OH - 1/1/2013
• Podocyturia May Predict Response and Survival in Patients with Solid Organ Tumors Treated with anti-VEGF Medications 
  San Diego, CA - 1/30/2012
• VEGF inhibition: renal toxicity and its effects on podocyte physiology 
  Rochester, MN - 1/24/2012
• Urinary Loss of Viable Podocytes is Associated with Bevacizumab-Induced Thrombotic Microangiopathy 
  Washington, DC - 1/9/2012
• Urinary Uromodulin (UU) Levels in Normal Human Renal Allografts, BK Nephropathy (BKN) and Acute Rejection 
  Boston, MA - 1/2/2012
• Urinary Uromodulin 1 Year after Kidney Transplant. Relationship to Histology and Graft Function 
  Philadelphia, PA - 1/30/2011
• Chronic Kidney Disease 
  1/28/2011
• Podocyturia in Patients Treated with Anti-VEGF Therapy for Cancer 
  Las Vegas, NV - 1/26/2011
• Acute Rejection in Renal Allografts with Delayed Graft Function (DGF) in the Era of T Cell Depleting Induction Agents 
  Las Vegas, NV - 1/26/2011
• Podocyturia Is an Early Marker That Distinguishes among Normotensive Pregnancy, Gestational Hypertension, and Preeclampsia 
  Philadelphia, PA - 1/8/2011
• Join now to see all